Rilmenidine sympatholytic activity preserves mental stress, orthostatic sympathetic responses and adrenaline secretion

Journal of Hypertension

Volumn 22, Issue 8, 2004, Pages 1529-1534

  Esler, Murray ^a   Lux, Alan ^a   Jennings, Garry ^a   Hastings, Jacqui ^a   Socratous, Flora ^a   Lambert, Gavin ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

High blood pressure; Imidazoline; Mental stress; Noradrenaline; Postural reflexes

Indexed keywords

NORADRENALIN; RILMENIDINE;

ADRENALIN RELEASE; ADRENERGIC ACTIVITY; ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; HEAD TILTING; HEART RATE; HUMAN; HYPERTENSION; MALE; MENTAL STRESS; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REFLEX; STANDING; SYSTOLIC BLOOD PRESSURE;

EID: 3843089433     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000125453.28861.b8     Document Type: Article

References (29)

1. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 1995; 26:1257-1263.
2. Packer M, Bristow MR, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334:1349-1355.
3. Leor J, Poole WK, Kloner RA. Sudden cardiac death triggered by an earthquake. N Engl J Med 1996; 334:413-419.
4. Rumantir MS, Vaz M, Jennings GL, Collier G, Kaye DM, Seals DR, et al. Neural mechanisms in human obesity-related hypertension. J Hypertens 1999; 17:1125-1133.
5. Grassi G, Colombo M, Seravalle G, Spaziani D, Mancia G. Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. Hypertension 1998; 31:64-67.
6. Narkiewicz K, Somers VK, Mos L, Kato M, Accurso V, Palatini P, et al. An independent relationship between plasma leptin and heart rate in untreated patients with essential hypertension J Hypertens 1999; 17:245-249.
7. Schlaich MP, Kaye DM, Lambert E, Sommerville M, Soctratous F, Esler MD. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 2003; 108:560-565.
8. Mann DL, Kent RL, Parsons B, Cooper G. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 1992; 85:790-804.
9. Julius S, Gundrandsson T, Jamerson K, Andersson O. The interconnection between sympathetics, microcirculation and insulin resistance in hypertension. Blood Press 1992; 1:9-19.
10. Esler M. Editorial review: assessment of sympathetic nervous function in humans from noradrenaline plasma kinetics. Clin Sci 1982; 62:247-254.
11. Ruzicka M, Leenen FHH. Relevance of intermittent increases in sympathetic activity for adverse outcome on short acting calcium antagonists. In: Laragh JH, Brenner BM (editors): Hypertension pathophysiology, diagnosis and management. New York: Raven Press; 1995, pp. 2815-2825.
12. Tibirica EJ, Feldman C, Mermet C, Monassier F, Gonon F, Bousquet P. Selectivity of rilmenidine for the nucleus reticularis lateralis, a ventrolateral medullary structure containing imidazoline-preferring receptors. Eur J Pharmacol 1991; 209:213-221.
13. Roegel J-C, Yannoulis N, De Jong W, Feldman J, Bousquet P. Preventive effect of rilmenidine on the occurrence of neurogenic ventricular arrhythmias in rabbits. J Hypertens 1998; 16 (suppl 3):S39-S43.
14. Genissel P, Bromet N, Fourtillan J, Mignot A, Albin H. Pharmacokinetics of rilmenidine in healthy subjects. Am J Cardiol 1988; 61:47D-53D.
15. Reid J. Update on rilmenidine: clinical benefits on sympathetic nervous system, I1 imidazoline receptors, hypertension and metabolic disorders. Am J Hypertens 2001; 14:322S-324S.
16. Medvedev OS, Esler MD, Angus JA, Cox HS, Eisenhofer G. Simultaneous determination of plasma noradrenaline and adrenaline kinetics: responses to nitroprusside-induced hypotension and 2-deoxyglucose-induced glucopenia in the rabbit. Naunyn Schmiedeberg's Arch Pharmacol 1990; 341:192-199.
17. Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate and functions. Physiol Rev 1990; 70:963-985.
18. Wallin BG, Esler M, Dorward P, Eisenhofer G, Ferrier C, Westerman R, et al. Simultaneous measurements of cardiac norepinephrine spillover and sympathetic outflow to skeletal muscle in humans. J Physiol (Lond) 1992; 453:45-56.
19. Meredith IT, Eisenhofer G, Lambert GW, Jennings GL, Ester MD. Plasma noradrenaline responses to head-up tilt are misleading in autonomic failure. Hypertension 1992; 19:628-633.
20. Manolis AJ, Olympios C, Sifaki M, Handanis S, Bresnahan M, Gavras I, Gavras H. Suppressing sympathetic activation in congestive heart failure: a new therapeutic strategy. Hypertension 1995; 26:719-724.
21. Esler M, Dudley F, Jennings G, Debinski H, Lambert G, Jones P, et al. Increased sympathetic nervous system activity, and effects of its pharmacological inhibition, in alcoholic cirrhosis. Ann Intern Med 1992; 116:446-455.
22. Ferrier C, Jennings GL, Eisenhofer G, Lambert G, Cox HS, Kalff V, et al. Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension. J Hypertens 1993; 11:1217-1227.
23. Lambert GW, Ferrier C, Kaye D, Cox HS, Turner AG, Jennings GL, et al. Monoaminergic neuronal activity in subcortical brain regions in essential hypertension. Blood Press 1994; 3:55-66.
24. Lambert GW, Kaye DM, Thompson JM, Turner AG, Cox HS, Vaz M, et al. Internal jugular venous spillover of noradrenaline and metabolites and their association with sympathetic nervous activity. Acta Physiol Scand 1998; 163:155-163.
25. Esler M, Meredith I. Responses of the human sympathetic nervous system to Stressors. In: Sheppard KE, Boublik JH, Funder JW (editors): Stress and reproduction. Ares Symposium Publications, vol. 86. New York: Raven Press; 1992, pp. 19-30.
26. Giuditta M, Del BoA. The Kolliker-Fuse nucleus in the control of the vasomotor activity and of the adrenal medulla. J Hypertens 2003; 21(suppl 4):S259.
27. Majewski H, Rand MJ, Tung LH. Activation of prejunctional β-adrenoceptors in rat atria by adrenaline applied exogenously or released as a co-transmitter. Br J Pharmacol 1981; 73:669-679.
28. Johansson M, Rundqvist B, Eisenhofer G, Friberg P. Cardiorenal epinephrine kinetics: evidence for release in the human heart. Am J Physiol 1997; 273:H2178-H2185.
29. Rumantir MS, Jennings GL, Lambert GW, Kaye DM, Seals DR, Esler MD. The 'adrenaline hypothesis' of hypertension revisited: evidence for adrenaline release from the heart of patients with essential hypertension. J Hypertens 2000; 18:717-723.